Article Versions Notes

Lin J-R, Huang S-H, Wu C-H, Chen Y-W, Hong Z-J, Cheng C-P, Sytwu H-K, Lin G-J. Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes. Pharmaceuticals. 2021; 14(5):475. https://doi.org/10.3390/ph14050475

Lin, Jeng-Rong, Shing-Hwa Huang, Chih-Hsiung Wu, Yuan-Wu Chen, Zhi-Jie Hong, Chia-Pi Cheng, Huey-Kang Sytwu, and Gu-Jiun Lin. 2021. "Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes" Pharmaceuticals 14, no. 5: 475. https://doi.org/10.3390/ph14050475

Lin, J. -R., Huang, S. -H., Wu, C. -H., Chen, Y. -W., Hong, Z. -J., Cheng, C. -P., Sytwu, H. -K., & Lin, G. -J. (2021). Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes. Pharmaceuticals, 14(5), 475. https://doi.org/10.3390/ph14050475